U.K. Pharmaceuticals & Biotech Big Green Snowflakes

hVIVO

Market Cap: UK£53.1m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

Hikma Pharmaceuticals

Market Cap: UK£4.1b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Animalcare Group

Market Cap: UK£161.4m

Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.

AstraZeneca

Market Cap: UK£193.1b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Bioventix

Market Cap: UK£128.0m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

ECO Animal Health Group

Market Cap: UK£63.7m

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally.

Genus

Market Cap: UK£1.7b

Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.

Haleon

Market Cap: UK£29.4b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

HUTCHMED (China)

Market Cap: UK£2.0b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

IXICO

Market Cap: UK£12.3m

Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.

GSK

Market Cap: UK£66.3b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Physiomics

Market Cap: UK£1.3m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

Oxford Biomedica

Market Cap: UK£716.3m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Poolbeg Pharma

Market Cap: UK£25.1m

A clinical-stage biopharmaceutical company, focused on acquiring, developing, and commercialising of medicines for unmet medical needs in the United Kingdom.

Oxford BioDynamics

Market Cap: UK£10.8m

Operates as a biotechnology company that discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom.

Shield Therapeutics

Market Cap: UK£82.8m

A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.

Ovoca Bio

Market Cap: UK£938.0k

A clinical-stage biopharmaceutical company, develops and commercializes novel product candidates for women health.

BSF Enterprise

Market Cap: UK£3.9m

Develops and commercializes cutting-edge tissue-engineered solutions.

ProBiotix Health

Market Cap: UK£10.3m

Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.

Verici Dx

Market Cap: UK£9.8m

Together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States.

Nuformix

Market Cap: UK£4.7m

Together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.

Diaceutics

Market Cap: UK£139.6m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

Incanthera

Market Cap: UK£3.4m

A dermatology and oncology therapeutics company, focuses on the dermatological formulation and delivery technologies for various indications.

Faron Pharmaceuticals Oy

Market Cap: UK£207.1m

Operates as a clinical stage drug discovery and development company.

Theracryf

Market Cap: UK£4.6m

A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders.

Futura Medical

Market Cap: UK£10.7m

Research, develops, and commercializes pharmaceutical and healthcare products for sexual health.

CRISM Therapeutics

Market Cap: UK£4.4m

Develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs.

4basebio

Market Cap: UK£119.9m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally.

PureTech Health

Market Cap: UK£340.3m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

N4 Pharma

Market Cap: UK£5.2m

A specialist pharmaceutical company, develops nanoparticle silica delivery systems to enhance the cellular delivery and potency of cancer treatments and vaccines in the United Kingdom.

SkinBioTherapeutics

Market Cap: UK£38.8m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.

Fusion Antibodies

Market Cap: UK£19.3m

A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.

Roquefort Therapeutics

Market Cap: UK£3.1m

A material biotech company, engages in the development of medicines for the treatment of cancer.

Oxford Nanopore Technologies

Market Cap: UK£1.5b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA.

genedrive

Market Cap: UK£1.5m

Engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications.

OptiBiotix Health

Market Cap: UK£11.4m

A life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.